BibTex RIS Cite

Translocation Carcinoma: Rare Case

Year 2015, Volume: 17 Issue: 3, 124 - 125, 01.12.2015

Abstract

Translocation carcinoma is a recently described tumour which was replaced in the latest WHOclassification. Translocation carcinoma comprises about 1/3 of pediatric renal tumours. In thiscase report, we aimed to discuss translocation carcinoma as an important differantial diagnosisin pediatric renal tumours

References

  • Eble JN, Togashi K, Pisani P. Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions. Ed: John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press Lyon, pp: 37-38, 2004
  • Gregory T. MacLennan, Liang Cheng, Translocation Carcinoma. Ed: David G. Bostwick, Liang Cheng, Urologic Surgical Pathology, pp:101, 2008
  • Robert O Petersen, Isabell A Sesterhenn, Charles J Davis, Urologic pathology. 3rd ed. Lippincott: Williams and Wilkins,pp: 64, 2008
  • Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A. Renal cell carcinoma associated with transcription factor E3 expression characteristics, and prognosis. .Am J Clin Pathol. 137(5):761- 8, 2012
  • Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 27(1):113-27, 2014 6.
  • Fall B, Sarr A, Sow Y, Diao B Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement. Afr J Paediatr Surg. ;8(3):317-9. 2011
  • Zhou AG, Owens CL, Cosar EF, Jiang Z. Arch Pathol Lab Med. 137(7):887-93, 2013
  • Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol.126(3):349- 64, 2006
  • Perlman EJ. Pediatric Renal Cell Carcinoma. Surg Pathol Clin. 3(3):641-651, 2010
  • Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.; Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement 22(2), pp: 107–111, 2013
  • Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, and Stephen M. Rohan Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine. Archives of Pathology & Laboratory Medicine,(37) 4, pp: 467-480, 2013

TRANSLOKASYON KARSİNOMU: NADİR VAKA

Year 2015, Volume: 17 Issue: 3, 124 - 125, 01.12.2015

Abstract

Translokasyon karsinomu, son WHO sınıflamasında yer alan yeni tanımlanmış bir tümördür.Pediatrik böbrek tümörlerinde 1/3 oranında görülür. Bu vaka sunumunda; pediatrik böbrektümörlerinde akılda tutulması gereken bir ayırıcı tanı olan translokasyon karsinomununtartışılması amaçlanmıştır

References

  • Eble JN, Togashi K, Pisani P. Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions. Ed: John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press Lyon, pp: 37-38, 2004
  • Gregory T. MacLennan, Liang Cheng, Translocation Carcinoma. Ed: David G. Bostwick, Liang Cheng, Urologic Surgical Pathology, pp:101, 2008
  • Robert O Petersen, Isabell A Sesterhenn, Charles J Davis, Urologic pathology. 3rd ed. Lippincott: Williams and Wilkins,pp: 64, 2008
  • Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A. Renal cell carcinoma associated with transcription factor E3 expression characteristics, and prognosis. .Am J Clin Pathol. 137(5):761- 8, 2012
  • Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 27(1):113-27, 2014 6.
  • Fall B, Sarr A, Sow Y, Diao B Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement. Afr J Paediatr Surg. ;8(3):317-9. 2011
  • Zhou AG, Owens CL, Cosar EF, Jiang Z. Arch Pathol Lab Med. 137(7):887-93, 2013
  • Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol.126(3):349- 64, 2006
  • Perlman EJ. Pediatric Renal Cell Carcinoma. Surg Pathol Clin. 3(3):641-651, 2010
  • Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.; Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement 22(2), pp: 107–111, 2013
  • Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, and Stephen M. Rohan Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine. Archives of Pathology & Laboratory Medicine,(37) 4, pp: 467-480, 2013
There are 11 citations in total.

Details

Primary Language Turkish
Journal Section Case Report
Authors

Nilüfer Kadıoğlu This is me

Ali Tekin This is me

Feyza Başar This is me

Hasan Rıza Aydın This is me

Murat Oktay This is me

Havva Erdem This is me

Publication Date December 1, 2015
Published in Issue Year 2015 Volume: 17 Issue: 3

Cite

APA Kadıoğlu, N., Tekin, A., Başar, F., Aydın, H. R., et al. (2015). TRANSLOKASYON KARSİNOMU: NADİR VAKA. Duzce Medical Journal, 17(3), 124-125.
AMA Kadıoğlu N, Tekin A, Başar F, Aydın HR, Oktay M, Erdem H. TRANSLOKASYON KARSİNOMU: NADİR VAKA. Duzce Med J. December 2015;17(3):124-125.
Chicago Kadıoğlu, Nilüfer, Ali Tekin, Feyza Başar, Hasan Rıza Aydın, Murat Oktay, and Havva Erdem. “TRANSLOKASYON KARSİNOMU: NADİR VAKA”. Duzce Medical Journal 17, no. 3 (December 2015): 124-25.
EndNote Kadıoğlu N, Tekin A, Başar F, Aydın HR, Oktay M, Erdem H (December 1, 2015) TRANSLOKASYON KARSİNOMU: NADİR VAKA. Duzce Medical Journal 17 3 124–125.
IEEE N. Kadıoğlu, A. Tekin, F. Başar, H. R. Aydın, M. Oktay, and H. Erdem, “TRANSLOKASYON KARSİNOMU: NADİR VAKA”, Duzce Med J, vol. 17, no. 3, pp. 124–125, 2015.
ISNAD Kadıoğlu, Nilüfer et al. “TRANSLOKASYON KARSİNOMU: NADİR VAKA”. Duzce Medical Journal 17/3 (December 2015), 124-125.
JAMA Kadıoğlu N, Tekin A, Başar F, Aydın HR, Oktay M, Erdem H. TRANSLOKASYON KARSİNOMU: NADİR VAKA. Duzce Med J. 2015;17:124–125.
MLA Kadıoğlu, Nilüfer et al. “TRANSLOKASYON KARSİNOMU: NADİR VAKA”. Duzce Medical Journal, vol. 17, no. 3, 2015, pp. 124-5.
Vancouver Kadıoğlu N, Tekin A, Başar F, Aydın HR, Oktay M, Erdem H. TRANSLOKASYON KARSİNOMU: NADİR VAKA. Duzce Med J. 2015;17(3):124-5.